Balancing Immunosuppressive Efficacy and Prevention of Posttransplant Diabetes—A Question of Timing and Patient Selection

[1]  E. Salido,et al.  Randomized Controlled Trial Assessing the Impact of Tacrolimus Versus Cyclosporine on the Incidence of Posttransplant Diabetes Mellitus , 2018, Kidney international reports.

[2]  D. Abramowicz,et al.  Prospective randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with posttransplant diabetes mellitus after renal transplantation , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  A. Henning,et al.  New‐Onset Diabetes After Transplantation: Results From a Double‐Blind Early Corticosteroid Withdrawal Trial , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  G. Pacini,et al.  Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  A. Tura,et al.  Early basal insulin therapy decreases new-onset diabetes after renal transplantation. , 2012, Journal of the American Society of Nephrology : JASN.

[6]  Richard D Moore,et al.  Influence of Lifestyle Modification in Renal Transplant Recipients With Postprandial Hyperglycemia , 2008, Transplantation.

[7]  D. Abramowicz,et al.  Conversion from tacrolimus to cyclosporine A for new‐onset diabetes after transplantation: a single‐centre experience in renal transplanted patients and review of the literature , 2007, Transplant international : official journal of the European Society for Organ Transplantation.

[8]  P. Halloran,et al.  Reduced exposure to calcineurin inhibitors in renal transplantation. , 2007, The New England journal of medicine.

[9]  S. Chadban,et al.  Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  Daniel C. Brennan,et al.  A Randomized, Prospective, Pharmacoeconomic Trial of Tacrolimus versus Cyclosporine in Combination with Thymoglobulin in Renal Transplant Recipients , 2005, Transplantation.